Risk Stratification of MDS
Amer Zeidan, MBBS, MHS, explains risk stratification in MDS, how the process has evolved over time, and the guidelines he typically follows.
Stay updated with breaking news from Recent Updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amer Zeidan, MBBS, MHS, explains risk stratification in MDS, how the process has evolved over time, and the guidelines he typically follows.
Hetty Carraway, MD, reviews how MDS is diagnosed and the common symptoms that patients who have MDS may present with.
A panel of experts who treat patients with non-small cell lung cancer provides an overview of staging, molecular testing and treatment options in stage I-IIIB non-small cell lung cancer.
Ben Levy, MD offers insight into how he approaches the selection of the optimal treatment strategy in early-stage non-small cell lung cancer.
Focused discussion on the incidence of chemotherapy-induced menopause in patients receiving treatment for their breast cancer.